Final exam Flashcards
Therapeutic milieu
Positive and safe physical settings, interactions, and activities that promote recovery.
Abstract thinking
Thinking characterized by the ability to use concepts and to make and understand generalizations, such as of the properties of pattern shared by a variety of specific items or events
Orientation phase
First time nurse and pt. meet. Focuses on building rapport
Working phase
Identifing and exploring issues and emotions
Termination phase
summarizing progress, ending relationship
Countertransference
Nurse responds emotionally to pt. as if they were a significant figure from the past
Transferance
pt. inappropriately displaces patterns of behavior or emotional reactions on person as if they were a significant figure from the past
acting out
(Immature defense) addressing emotional conflicts or stressors by actions rather than reflections of feelings
Splitting
(immature defense) inability to combine the positive and negative aspects of people
Cognitive behavioral therapy (CBT)
seeks to modify negative thoughts that lead to dysfunctional emotions and actions
autocratic leadership
(controls group) does not encourage interaction among members
Free association
Mental process by which one word or image may spontaneously suggest another without any apparent connection
Acetylcholine
Cholinergic neurotransmitters
-increase in depression
-decrease in Alzheimers
Adrenergic
Sympathetic NS “fight of flight”
NT - norepinephrine & epinephrine binds to alpha and beta receptor sites
Antipsychotics
block dopamine
Extrapyramidal symptoms
side effects of antipsychotics
- pseudoparkinsonisms, akathisia, acute dystonic reactions, tardive dyskinesia, neuroleptic malignant syndrome
Monoamine oxidase inhibitors (MAOIs)
Inhibit the enzyme monoamine oxidase from breaking down monoamines (ex. norepinephrine)
- excess tyramine w/ medication cases hypertensive crisis
Neuroleptic Malignant syndrome
Potentially fatal
- Muscle rigidity, tremor, diaphoresis, hypertension, tachycardia, hyperexia, incontinence
NMS treatment
Discontinue medications, transfer to ICU, treat autonomic dysfunction (Diaphoresis, hypertnesion, tachycardia, hyperexia, incontinence)
Norepinephrine
Monoamine
- increased in schizophrenia, mania, anxiety
- decreased in depression
Psuedoparkinsonism
Body destroys ability to move dopamine
- masklike face, stiff & stooped posture, shuffling gait, drooling
- treat w/ diphenhydramine
Akathisia
Inner restlessness, rocking, tapping foot, pacing, cannot fix range of motion
treat
-Treat w/ diphenhydramine
Anticholinergic
Blocks acetylcholine from attaching to receptor
-blocks rest & digest
Antidepressant
Decreased levels of serotonin, norepinephrine, and dopamine
-4-6 weeks of treatment to reach normal levels
Dopamine
Monoamine
-increased in schizophrenia & mania
-decreased in depression
y-aminobutyric acid (GABA)
GABAa and b
-decreases mania, anxiety, and schizophrenia
tardive dyskinesia
Constant movement, tongue thrusting or lip smacking
- discontinue medication
Serotonin syndrome
Side effect of SSRI’s
-high fever, high BP, tachycardia, agiation
-over stimulation of serotonin receptors; common when 2 SSRIs are used together
anergia
lack of energy
Electroconvulsive therapy
3 indications
- drug therapy failed
- pt. is acutely suicidal
- depressed pt is experiencing suicidal symptoms
Major depressive disorder
Emotional, cognitive, & behavioral symptoms that interfere w/ a person’s life
- history of one or more episodes of major depression
Vagus nerve stimulation
Adjunct, long term treatment of pts. w/ treatment-resistant depression
-affects blood flow in the brain
Dysthymia
(persistent depressive disorder)
-functional
-mild-to-moderate depression
-at least 2 yrs of duration